|1.||Fletcher, Christopher D M: 6 articles (04/2011 - 07/2005)|
|2.||Hornick, Jason L: 6 articles (04/2011 - 07/2005)|
|3.||Oliva, Esther: 5 articles (07/2015 - 04/2002)|
|4.||Zheng, Ping-Pin: 5 articles (02/2009 - 08/2003)|
|5.||Kros, Johan M: 5 articles (02/2009 - 08/2003)|
|6.||Kuroda, Naoto: 4 articles (07/2009 - 01/2004)|
|7.||Enzan, Hideaki: 4 articles (06/2007 - 01/2002)|
|8.||Suzuki, T: 4 articles (12/2001 - 05/2000)|
|9.||Watanabe, K: 4 articles (12/2001 - 05/2000)|
|10.||Terrier, Philippe: 3 articles (06/2014 - 09/2007)|
|1.||Synovial Sarcoma (Synovioma)
06/01/2003 - "H-caldesmon is not helpful in diagnosis of synovial sarcoma."
06/01/2003 - "Four synovial sarcomas showed focal reactivity for h-caldesmon. "
06/01/2003 - "To assess the frequency of expression and potential diagnostic utility of calponin and caldesmon in synovial sarcomas. "
06/01/2003 - "Calponin and h-caldesmon expression in synovial sarcoma; the use of calponin in diagnosis."
06/01/2003 - "Immunohistochemistry with antibodies to calponin and h-caldesmon was undertaken in paraffin sections from 50 synovial sarcomas (19 biphasic and 31 monophasic, of which one biphasic and eight monophasic tumours had poorly differentiated areas), 10 each of malignant peripheral nerve sheath tumour (MPNST), solitary fibrous tumour (SFT), dermatofibrosarcoma (DFSP), Ewing's sarcoma (ES/PNET), and neuroblastoma, eight alveolar rhabdomyosarcomas, five adult fibrosarcomas and five carcinosarcomas. "
04/01/2007 - "In a previous study we found that the low molecular caldesmon isoform (Hela l-CaD) is expressed in endothelial cells (ECs)/endothelial progenitor cells (EPCs) in tumor vasculature of various human tumors. "
07/01/2004 - "This study confirms the value of h-caldesmon in the distinction between an endometrial stromal neoplasm (almost always h-caldesmon negative) and a cellular leiomyomatous neoplasm (h-caldesmon positive). "
02/01/2014 - "31 SMNs and 111 potential differential diagnoses (16 different neoplasm types) were immunostained for caldesmon, PLAP and smoothelin. "
01/01/2014 - "However, the desmoplastic areas of these tumors, composed of spindled fibroblasts and myofibroblasts, showed negative immunostaining for caldesmon and smoothelin (0/35). "
01/01/2014 - "Immunohistochemical staining using smooth muscle actin (SMA), smoothelin, and caldesmon were performed on 51 cases: 8 cases of pT1 tumors (used mainly as control); 12 pT2 tumors; and 31 pT3 tumors. "
|3.||Neoplasm Metastasis (Metastasis)
06/01/2009 - "This study reports a novel molecular mechanism (caldesmon), as well as a structural basis (podosomes/rosettes), to show how p53 can act as an anti-motility/invasion/metastasis agent."
01/01/2014 - "The aim of this study is to elucidate the relationship between the expressions of iNOS, cytoskeleton protein caldesmon, OPN, and clinical parameters especially the metastasis of lung cancer. "
02/01/2013 - "This study has thus established the potential role of caldesmon in gastric cancer metastasis, and further functional studies are underway to delineate the underlying mechanism of action of this protein."
07/01/2011 - "Studies with transformed and cancer cell lines suggest that a reduction in l-caldesmon facilitates podosome/invadopodia formation and metastasis. "
01/01/2014 - "The expressions of iNOS, caldesmon, and OPN are closely correlated to metastasis of lung cancer. "
05/01/2010 - "On the basis of this study, h-caldesmon is not a useful marker for mesothelioma."
04/01/2006 - "h-Caldesmon, a useful positive marker in the diagnosis of pleural malignant mesothelioma, epithelioid type."
05/01/2010 - "The goal of this study was to evaluate whether PAX8 and h-caldesmon expression can successfully distinguish mesothelioma from serous ovarian tumors. "
05/01/2010 - "In addition, some studies suggest that h-caldesmon is sensitive and specific for mesothelioma when compared with serous ovarian tumors. "
04/01/2013 - "All of the serous carcinomas and mesotheliomas were negative for h-caldesmon. "
|5.||Smooth Muscle Tumor
04/01/2002 - "4) The absence of h-caldesmon in UTROSCTs helps separate them from epithelioid smooth muscle tumors. "
05/01/2000 - "Its isoform, high-molecular-weight caldesmon (h-CD), was demonstrated to be specific for smooth muscle cells and smooth muscle tumors of the soft tissue and to never be expressed in myofibroblasts. "
05/01/2000 - "h-Caldesmon as a specific marker for smooth muscle tumors. "
09/01/2008 - "The importance of CD10 and h-Caldesmon in the distinction of smooth muscle tumors of the uterus and endometrial stromal sarcoma."
04/01/2002 - "h-caldesmon was positive in almost all nonepithelioid smooth muscle tumors and in areas of smooth muscle differentiation in endometrial stromal tumors; it was positive in only about half of the epithelioid smooth muscle tumors and negative in all UTROSCTs. "
|4.||Proteins (Proteins, Gene)
|6.||Calmodulin (Calcium-Dependent Activator Protein)
|7.||Myosin Heavy Chains (Myosin Heavy Chain)
|8.||Carrier Proteins (Binding Protein)
|10.||Protein Isoforms (Isoforms)
|2.||Angioplasty (Angioplasty, Transluminal)